CLINICAL AND VIROLOGIC RESPONSES TO A RECOMBINANT VACCINIA HIV-1 GP160 VACCINE (HIVAC-1E)

被引：0
|
作者：
COREY, L
COLLIER, A
COOMBS, R
ARDITTI, D
HU, SL
GREENBERG, P
MCLAREN, C
MARTIN, R
DRAGAVON, J
CHALOUPKA, K
机构：
[1] UNIV WASHINGTON,SEATTLE,WA 98195
[2] BRISTOL MYERS CORP,WALLINGFORD,CT
来源：
CLINICAL RESEARCH | 1989年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A562 / A562
页数：1
相关论文
共 50 条
  • [1] DEVELOPMENT OF A VACCINIA RECOMBINANT DERIVED SUBUNIT HIV-1 GP160 CANDIDATE VACCINE
    BARRETT, N
    MITTERER, A
    GERENCER, M
    EIBL, J
    EIBL, M
    GALLO, RC
    MOSS, B
    DORNER, F
    VACCINES FOR SEXUALLY TRANSMITTED DISEASES, 1989, : 244 - 249
  • [2] HIV-1 RECOMBINANT GP160 VACCINE GIVEN IN ACCELERATED DOSE SCHEDULES
    GORSE, GJ
    SCHWARTZ, DH
    GRAHAM, BS
    MATTHEWS, TJ
    STABLEIN, DM
    FREY, SE
    BELSHE, RB
    CLEMENTS, ML
    WRIGHT, PF
    EIBL, M
    FAST, PE
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 98 (02): : 178 - 184
  • [3] HIV-1 RECOMBINANT GP160 VACCINE GIVEN IN ACCELERATED DOSE SCHEDULES
    DEPALMA, L
    PEDIATRIC AIDS AND HIV INFECTION-FETUS TO ADOLESCENT, 1995, 6 (02): : 97 - 98
  • [4] SERUM ANTIBODIES TO HIV-1 IN RECOMBINANT VACCINIA VIRUS RECIPIENTS BOOSTED WITH PURIFIED RECOMBINANT GP160
    MONTEFIORI, DC
    GRAHAM, BS
    KLIKS, S
    WRIGHT, PF
    JOURNAL OF CLINICAL IMMUNOLOGY, 1992, 12 (06) : 429 - 439
  • [5] HIV-1 RECOMBINANT GP160 VACCINE-INDUCED ANTIBODIES IN SERUM AND SALIVA
    GORSE, GJ
    ROGERS, JH
    PERRY, JE
    NEWMAN, FK
    FREY, SE
    PATEL, GB
    BELSHE, RB
    SCHWARTZ, DH
    CLEMENTS, ML
    KEEFER, M
    DOLIN, R
    MCELRATH, J
    COREY, L
    GRAHAM, BS
    WRIGHT, PF
    STABLEIN, DM
    MATTHEWS, TJ
    BOLOGNESI, D
    MESTECKY, J
    WALKER, MC
    FAST, PE
    VACCINE, 1995, 13 (02) : 209 - 214
  • [6] CHARACTERIZATION OF SERUM ANTIBODY-RESPONSES TO RECOMBINANT HIV-1 GP160 VACCINE BY ENZYME-IMMUNOASSAY
    VISCIDI, R
    ELLERBECK, E
    GARRISON, L
    MIDTHUN, K
    CLEMENTS, ML
    CLAYMAN, B
    FERNIE, B
    SMITH, G
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (11) : 1251 - 1256
  • [7] HUMAN-IMMUNODEFICIENCY-VIRUS (HIV-1) GP160-SPECIFIC LYMPHOCYTE PROLIFERATIVE RESPONSES OF MONONUCLEAR LEUKOCYTES FROM HIV-1 RECOMBINANT GP160 VACCINE RECIPIENTS
    KEEFER, MC
    BONNEZ, W
    ROBERTS, NJ
    DOLIN, R
    REICHMAN, RC
    JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03): : 448 - 453
  • [8] Immune responses to a recombinant human immunodeficiency virus type 1 (HIV-1) gp160 vaccine among adults with advanced HIV infection
    DeMaria, A
    Kunches, L
    Mayer, K
    Cohen, C
    Epstein, P
    Werner, B
    Day, J
    DeCristofaro, J
    Landers, S
    Tang, Y
    Coady, W
    JOURNAL OF HUMAN VIROLOGY, 2000, 3 (04) : 182 - 192
  • [9] Effect of therapeutic immunization with recombinant gp160 HIV-1 vaccine on HIV-1 proviral DNA and plasma RNA: Relationship to cellular immune responses
    Kundu, SK
    Katzenstein, D
    Valentine, FT
    Spino, C
    Efron, B
    Merigan, TC
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 15 (04): : 269 - 274
  • [10] Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine
    Lambert, JS
    Viscidi, R
    Walker, MC
    Clayman, B
    Winget, M
    Wolff, M
    Schwartz, DH
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (03) : 302 - 308
12345